Finding cures for children's genetic diseases


Image 1 of
  • Biomedical Proteomics Unit
    Biomedical Proteomics Unit

Biomedical Proteomics

Biomedical Proteomics at CMRI is a collaborative research resource that combines applied proteomics with the development of Mass Spectrometry (MS)-based qualitative and quantitative methods for protein identification and characterisation.

The facility supports CMRI and the Westmead Research Hub, as well as collaborations with groups and individuals from around Australia and the world by offering access to equipment and methodology, as well as expertise in the assessment of feasibility and strategy development for projects and programs involving MS-based proteomics analysis.

The Biomedical Proteomics Facility


In 2009-11, CMRI undertook a full refurbishment and extensive upgrade of the facility. Major funding from the Cancer Institute NSW (CINSW), the Australian Research Council Linkage Infrastructure, Equipment and Facilities scheme (ARC LIEF), and the Ian Potter Foundation provided two MS systems for advanced phosphoproteomicsresearch.

Four additional MS systems were purchased with generous funding from the Australian Cancer Research Foundation (ACRF) and the Ramaciotti Foundations to equip the new Australian Cancer Research Foundation Centre for Kinomics (ACRF-CFK). Most recently, 2 cutting-edge MS systems were purchased thanks to generous funding from the Zero Childhood Cancer program.

Currently the facility houses a total of eight state-of-the-art mass spectrometry systems.

Facility Access

If you believe an MS-based proteomics approach is suitable for your research, please discuss with your Research Project Leader who can then discuss the project feasibility, funding, expected time frame, access to Facility resources, and suitable candidates with the Facility Manager, Val Valova.